Journal Of Scleroderma And Related Disorders impact factor, indexing, ranking (2024)


journal

Aim and Scope

The Journal Of Scleroderma And Related Disorders is a research journal that publishes research related to Immunology and Microbiology; Medicine. This journal is published by the SAGE Publications Ltd. The ISSN of this journal is 23971991, 23971983. Based on the Scopus data, the SCImago Journal Rank (SJR) of journal of scleroderma and related disorders is 0.545.

Also, please check the following important details about journal of scleroderma and related disorders: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Journal Of Scleroderma And Related Disorders Ranking

Impact Factor: 1.4
5-Year JIF: 2
SJR (SCImago Journal Rank): 0.545
Quartile: Q3

The latest Impact Factor list (JCR) is released in June 2024.

The Impact Factor of Journal Of Scleroderma And Related Disorders is 1.4.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Journal of Scleroderma and Related Disorders
Publisher: SAGE Publications Ltd
ISSN: 23971991, 23971983
Type: journal
Journal Scope: Immunology and Microbiology; Medicine
Country: Italy
H-Index: 18
SJR: 0.545
Quartile: Immunology (Q3); Immunology and Allergy (Q3); Rheumatology (Q3)

Indexing

The journal of scleroderma and related disorders is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Journal Of Scleroderma And Related Disorders Impact Factor 2024

The latest impact factor of journal of scleroderma and related disorders is 1.4 which is recently updated in June, 2024.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Quartile

The latest Quartile of journal of scleroderma and related disorders is Q3.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Journal Publication Time

The publication time may vary depending on factors such as the complexity of the research and the current workload of the editorial team. Journals typically request reviewers to submit their reviews within 3-4 weeks. However, some journals lack mechanisms to enforce this deadline, making it difficult to predict the duration of the peer review process.

The review time also depends upon the quality of the research paper.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Journal Of Scleroderma And Related Disorders?

If your research is related to Immunology and Microbiology; Medicine, then visit the official website of journal of scleroderma and related disorders and send your manuscript.

Tips for publishing in Journal Of Scleroderma And Related Disorders:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of journal of scleroderma and related disorders is 1.4.
  • The journal of scleroderma and related disorders is a reputed research journal.
  • It is published by SAGE Publications Ltd.
  • The journal is indexed in UGC CARE, Scopus, ESCI.
  • The (SJR) SCImago Journal Rank is 0.545.

Sources: journal of scleroderma and related disorders







SIMILIAR JOURNALS


JOURNAL OF ANTIBIOTICS

ISSN: 0021-8820
Publisher: SPRINGERNATURE

INNATE IMMUNITY

ISSN: 1753-4259
Publisher: SAGE PUBLICATIONS LTD

INDIAN JOURNAL OF MEDICAL RESEARCH

ISSN: 0971-5916
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONS

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

ISSN: 1217-8950
Publisher: AKADEMIAI KIADO ZRT

APMIS

ISSN: 0903-4641
Publisher: WILEY

CLINICAL INFECTIOUS DISEASES

ISSN: 1058-4838
Publisher: OXFORD UNIV PRESS INC

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES

ISSN: 0147-9571
Publisher: ELSEVIER SCI LTD

EMERGING MICROBES & INFECTIONS

ISSN:
Publisher: TAYLOR & FRANCIS LTD

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY

ISSN: 2235-2988
Publisher: FRONTIERS MEDIA SA

HUMAN VACCINES & IMMUNOTHERAPEUTICS

ISSN: 2164-5515
Publisher: TAYLOR & FRANCIS INC

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.